Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Disorder of Glucose Regulation
- Sponsor
- German Institute of Human Nutrition
- Enrollment
- 97
- Locations
- 1
- Primary Endpoint
- Area under the curve (AUC): changes of expression levels of the sweet , bitter und umami taste receptors in humans in the upper bowel and responses of incretins to receptor agonists and antagonists
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
We investigate the impact of taste receptors (sweet, bitter and umami) on human metabolism. There ist growing evidence, that components of the taste signalling system, including the taste receptor proteins , have important functions in the regulation of metabolic parameters in non-gustatory tissues.
Detailed Description
We apply different sweet, bitter and umami taste compounds in a single dose in the human intervention. We use substances as for instance glucose, sucrose,saccharin and lactisol in the sweet part, and substances from cabbage, beer or red endive in the bitter part. For umami we take glutamate. Blood samples are collected at baseline and 6 times thereafter up to 3hours, to analyse the incretins GLP-1(glucagon-like peptide 1) and GIP(gastrointestinal polypeptide) and other peptide hormones as insulin and PYY(peptide tyrosin trosin) in human beings. Gastrointestinal mucosa is taken by gastroscopy from the lower duodenum from study subjects for analysis for the presence or absence of functional taste receptors in gastrointestinal tissues.
Investigators
Prof. Dr. med. Andreas F. H. Pfeiffer
Prof. Dr. med.
German Institute of Human Nutrition
Eligibility Criteria
Inclusion Criteria
- •Healthy persons
Exclusion Criteria
- •Tumor in history
- •Pregnancy
- •Severe illness in history
- •Bodymass index below 18
Outcomes
Primary Outcomes
Area under the curve (AUC): changes of expression levels of the sweet , bitter und umami taste receptors in humans in the upper bowel and responses of incretins to receptor agonists and antagonists
Time Frame: three years
measurement of incretins (GIP, GLP-1) and peptide hormones in human plasma after consumption of different sugars , sweeteners , bitter tasting ingredients of vegetables und umami. Measurement of expression levels in human intestinal mucosa before and after receptor stimulation
Secondary Outcomes
- changes in the signalling cascade of the sweet receptor SGLT1 (sodium tranporter 1), changes of receptor expression(3 years)